#UTIConference day 2 is a great mix of #UTI research🔬 (host🧍♀️ & pathogen 🦠) and clinical 🩺
PANEL: DIAGNOSIS OF UTI 🩺
SESSION 1: MICROBIAL PATHOGENESIS 🦠
SESSION 2: TREATMENT OF UTI 🩺
SESSION 3: COMORBIDITIES OF UTI 🤒
SESSION 4: IMMUNOLOGICAL RESPONSES TO UTI 💉💊🧘♂
The ASM wishes to congratulate The University of Western Australia’s Nobel Laureate Professor Barry Marshall on receiving The China International Science and Technology Cooperation Award for his work with Helicobacter and gastric cancer.
Read more here: https://t.co/SrVsmK5rjW
Our very first #SpeakerSpotlight is @MarkSchembri7, of @UQ_SCMB 🐨🇦🇺🦘
Dr. Schembri is a #UTI expert with over 20 years of experience. He's coming up from all the way down under for his talk "Antibiotic resistant uropathogenic E. coli - it's all about the clones"
Our next keynote #SpeakerSpotlight mixes things up a little and shifts from the bench ���to the bedside 🏥. We love variety!
@AnnStapletonMD of @UWDeptMedicine 🇺🇲🦅has over 30 years of #UTI expertise under her belt, clinical and research. (1/2)
#SpeakerSpotlight meet our 3rd keynote speaker, Dr. @Chels_A_micro (Chelsea Armbruster) of @Jacobs_Med_UB 🦅🇺🇲
Dr. Armbruster's lab studies how bacteria interact with their hosts 🦠🤝🧍♀️ and with each other 🦠 🤝🦠🤝🦠 to promote diseases like #catheter-associated #UTI. (1/2)
Our latest research published today in eLife. Great work led by @nhunguyen2811 and with a fantastic team of Australian and international collaborators.
https://t.co/FXnyk4ikUX @eLife
Our latest research published today in eLife. Great work led by @nhunguyen2811 and with a fantastic team of Australian and international collaborators.
https://t.co/SUMgEvsg89
We combined TraDIS and metabolomics to identify new genes required for growth in human urine by multidrug-resistant Escherichia coli ST131 in a study led by @pmduy in collaboration with @KapplerUlrike and @MetaboHorst https://t.co/WsSKcALC6H
Congratulations to Seweryn Bialasiewicz and Nichollas Scott who recently were both made Fellows of the Australian Society for Microbiology @AUSSOCMIC@ASM_VicBranch
We combined TraDIS and metabolomics to identify new genes required for growth in human urine by multidrug-resistant Escherichia coli ST131 in a study led by @pmduy in collaboration with @KapplerUlrike and @MetaboHorst https://t.co/WsSKcALC6H
#UQ researchers have discovered that a mutation allows some E. coli bacteria to invade the body while others are harmless, a finding that could help fight antibiotic resistance.
Read more about the @IMatUQ finding via @IFLScience https://t.co/rqoXNVg9XZ
I'm excited to share that our research from
@TheSweetGroup, on cystic fibrosis and how the heavy metal zinc could be beneficial in combating infections associated with CF, has finally been published in PNAS. https://t.co/JP9zhM4OZk
Many thanks to everyone involved in this project
Congratulations, TRI-based A/Prof @sumaira_hasnain from @MaterResearch for your collaborative work with @UQ_News@IMBatUQ researchers on tackling antibiotic resistant bacteria - with potential to address the threat of UTIs, meningitis and sepsis. https://t.co/hzkwOKSMp3
#UQ researchers have identified that an immune response fault leaves people living with #cysticfibrosis at risk of recurring infections.
The @IMBatUQ team says a zinc transport protein could be the answer to reducing illness.
Read more: https://t.co/pk6EuXE6Ob 📸Adobe
Researchers at @IMBatUQ have discovered why some E. coli bacteria cause severe disease and others don't.
@LabSchembri says a mutation helps affected bacteria spread in the body, a finding that could help fight antibiotic resistance.
Read more: https://t.co/XYRdAtooIk 📸Adobe